<?xml version="1.0" encoding="UTF-8"?>
<p>In addition to the above mentioned study, other clinical trials involving patients with solid tumors including colorectal carcinoma, breast cancer, hepatocellular carcinoma and lung cancer have been completed with encouraging results. In all these studies, ARTs inhibited growth of solid tumors with no evident toxicity and with a low incidence of adverse effects thus highlighting their role as promising anti-cancer agents [
 <xref rid="B54-medicina-57-00217" ref-type="bibr">54</xref>,
 <xref rid="B56-medicina-57-00217" ref-type="bibr">56</xref>,
 <xref rid="B57-medicina-57-00217" ref-type="bibr">57</xref>].
</p>
